Shanghai Fosun Pharmaceutical (Group) Co., Ltd. insider trades: Natures Sunshine Products (NATR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Shanghai Fosun Pharmaceutical (Group) Co., Ltd. reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 27, 2025 | NATR | ↓ Sell | 2,854,607 | $11.46 | $32.7M | by Fosun Pharma USA Inc. | Jun 27, 2025 (0d) |
| Oct 15, 2024 | NATR | ↓ Sell | 2,300 | $13.02 | $30K | by Fosun Industrial Co., Limited | Oct 17, 2024 (2d) |
| Oct 14, 2024 | NATR | ↓ Sell | 10,895 | $13.33 | $145K | by Fosun Industrial Co., Limited | Oct 15, 2024 (1d) |
| Dec 4, 2018 | CFRX | ↓ Sell | 600,000 | $2.04 | $1.2M | by Fosun Industrial Co., Limited | Dec 6, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NATR insiders
Open-market trades in the last 12 months
About Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s insider trades
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is an insider at Natures Sunshine Products (NATR). Since Dec 4, 2018, it has reported no open-market purchases and 4 sales worth $34.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NATR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.